AlphaVax, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Durham North Carolina United States (1997)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2003
NCT00063778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

avx502 (2 trials)

avx701 (2 trials)

Drugs in Phase 1 Trials (2)

avx101 (2 trials)

avx601 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 2)

Cytomegalovirus Infections (Phase 1)

HIV Infections (Phase 1)

Influenza, Human (Phase 2)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 4